Please enable JavaScript to continue using this application.

Compare tickers

Valuation, margins, and growth side by side.

Compare $AXNX vs $BMRA | Chartloom

Compare

$AXNX vs $BMRA

Axonics Inc · Biomerica Inc

AXNX

Axonics Inc

BMRA

Biomerica Inc

Compare $AXNX vs $BMRA

Comparing Axonics Inc and Biomerica Inc

AXNXAxonics Inc

BMRABiomerica Inc

AXNXAxonics Inc

Market cap

$36M

P/E (TTM)

—

Forward P/E (NTM)

1.40x

Forward P/S (NTM)

0.07x

Rev growth (TTM)

26.1%

YTD performance

-0.1%

52W performance

-98.8%

FCF yield

14.8%

BMRABiomerica Inc

Market cap

$6M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

-16.2%

YTD performance

-26.9%

52W performance

-34.6%

FCF yield

-60.5%

Add ticker

Add up to 1 more ticker to compare

Relative performance

Each ticker starts at 100. 110 means +10% from the start of this window — not a $110 share price.

AXNX

BMRA

Not enough overlapping price history for this window.

Detailed metrics comparison

AXNX

Axonics Inc

BMRA

Biomerica Inc

Market Cap

AXNX$36M

BMRA$6M

Enterprise Value

AXNX$-203M

BMRA$5M

Price

AXNX$0.71

BMRA$1.85

P/E Ratio

AXNXN/A

BMRAN/A

P/S Ratio

AXNX0.08x

BMRA1.28x

EV/Sales

AXNX-0.47x

BMRA1.10x

EV/EBITDA

AXNX-58.64x

BMRA29.35x

P/B Ratio

AXNX0.02x

BMRA3.21x

P/FCF Ratio

AXNX6.75x

BMRAN/A

EV/FCF

AXNX-37.80x

BMRA-1.42x

PEG Ratio

AXNXN/A

BMRAN/A

Forward P/E (NTM)

AXNX1.40x

BMRAN/A

Forward P/S (NTM)

AXNX0.07x

BMRAN/A

Revenue (TTM)

AXNX$432M

BMRA$4M

Revenue Growth (YoY)

AXNX26.1%

BMRA-16.2%

Forward Rev Growth

AXNX0.0%

BMRA0.0%

Gross Margin (TTM)

AXNX76.6%

BMRA8.1%

Operating Margin (TTM)

AXNX0.0%

BMRA0.0%

EBITDA Margin (TTM)

AXNX1.2%

BMRA-117.8%

Net Margin (TTM)

AXNX-1.3%

BMRA-84.8%

FCF Margin (TTM)

AXNX1.2%

BMRA-77.7%

Net Income (TTM)

AXNX$-6M

BMRA$-4M

FCF (TTM)

AXNX$5M

BMRA$-3M

EPS (TTM)

AXNX-$0.11

BMRA-$1.22

ROE (TTM)

AXNX-88.0%

BMRA-9719.0%

ROA (TTM)

AXNX-77.0%

BMRA-6157.0%

ROIC (TTM)

AXNX-88.0%

BMRA-9416.0%

Cash

AXNX$239M

BMRA$1M

Debt

AXNX$0

BMRA$500K

Net Cash/Debt

AXNX$239M

BMRA$808K

Current Ratio (TTM)

AXNX8.16x

BMRA1.62x

Quick Ratio (TTM)

AXNX6.33x

BMRA0.84x

Debt/Equity (TTM)

AXNX0.00x

BMRA0.19x

Debt/Assets (TTM)

AXNX0.0%

BMRA0.0%

Interest Coverage (TTM)

AXNXN/A

BMRAN/A

Net Debt/EBITDA (TTM)

AXNX0.00x

BMRA0.00x

Beta

AXNX3.24

BMRA0.39

52W Performance

AXNX-98.8%

BMRA-34.6%

YTD Performance

AXNX-0.1%

BMRA-26.9%

% from 52W High

AXNX-99.0%

BMRA-42.4%

% from 52W Low

AXNX1.4%

BMRA27.6%

Asset Turnover (TTM)

AXNX0.58x

BMRA0.73x

FCF Yield (TTM)

AXNX14.8%

BMRA-60.5%

Earnings Yield (TTM)

AXNX-15.6%

BMRA-66.0%

Dividend Yield (TTM)

AXNXN/A

BMRAN/A

Rule of 40

AXNX27.3

BMRA-93.8

EV/GP/RG

AXNXN/A

BMRAN/A

Ticker research

View AXNX research View BMRA research

Metric	AXNX Axonics Inc	BMRA Biomerica Inc
Market & Valuation
Market Cap	$36M	$6M
Enterprise Value	$-203M	$5M
Price	$0.71	$1.85
P/E Ratio	N/A	N/A
P/S Ratio	0.08x	1.28x
EV/Sales	-0.47x	1.10x
EV/EBITDA	-58.64x	29.35x
P/B Ratio	0.02x	3.21x
P/FCF Ratio	6.75x	N/A
EV/FCF	-37.80x	-1.42x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	1.40x	N/A
Forward P/S (NTM)	0.07x	N/A
Revenue & Growth
Revenue (TTM)	$432M	$4M
Revenue Growth (YoY)	26.1%	-16.2%
Forward Rev Growth	0.0%	0.0%
Profitability
Gross Margin (TTM)	76.6%	8.1%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	1.2%	-117.8%
Net Margin (TTM)	-1.3%	-84.8%
FCF Margin (TTM)	1.2%	-77.7%
Net Income (TTM)	$-6M	$-4M
FCF (TTM)	$5M	$-3M
EPS (TTM)	-$0.11	-$1.22
ROE (TTM)	-88.0%	-9719.0%
ROA (TTM)	-77.0%	-6157.0%
ROIC (TTM)	-88.0%	-9416.0%
Financial Health
Cash	$239M	$1M
Debt	$0	$500K
Net Cash/Debt	$239M	$808K
Current Ratio (TTM)	8.16x	1.62x
Quick Ratio (TTM)	6.33x	0.84x
Debt/Equity (TTM)	0.00x	0.19x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	3.24	0.39
52W Performance	-98.8%	-34.6%
YTD Performance	-0.1%	-26.9%
% from 52W High	-99.0%	-42.4%
% from 52W Low	1.4%	27.6%
Efficiency & Yields
Asset Turnover (TTM)	0.58x	0.73x
FCF Yield (TTM)	14.8%	-60.5%
Earnings Yield (TTM)	-15.6%	-66.0%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	27.3	-93.8
EV/GP/RG	N/A	N/A
Ticker research	View AXNX research	View BMRA research

Valuation

P/S Ratio

AXNX

0.08x

BMRA

1.28x

EV/FCF

AXNX

-37.80x

BMRA

-1.42x

Growth & revenue

Revenue Growth TTM

AXNX

26.1%

BMRA

-16.2%

Forward Revenue Growth

AXNX

0.0%

BMRA

0.0%

Profitability & performance

Gross Margin

AXNX

76.6%

BMRA

8.1%

ROE

AXNX

-88.0%

BMRA

-9719.0%

FCF Yield %

AXNX

14.8%

BMRA

-60.5%

52-Week Performance

BMRA

-34.6%

AXNX

-98.8%

Detailed metrics comparison

AXNX

Axonics Inc

BMRA

Biomerica Inc

Market Cap

AXNX$36M

BMRA$6M

Enterprise Value

AXNX$-203M

BMRA$5M

Price

AXNX$0.71

BMRA$1.85

P/E Ratio

AXNXN/A

BMRAN/A

P/S Ratio

AXNX0.08x

BMRA1.28x

EV/Sales

AXNX-0.47x

BMRA1.10x

EV/EBITDA

AXNX-58.64x

BMRA29.35x

P/B Ratio

AXNX0.02x

BMRA3.21x

P/FCF Ratio

AXNX6.75x

BMRAN/A

EV/FCF

AXNX-37.80x

BMRA-1.42x

PEG Ratio

AXNXN/A

BMRAN/A

Forward P/E (NTM)

AXNX1.40x

BMRAN/A

Forward P/S (NTM)

AXNX0.07x

BMRAN/A

Revenue (TTM)

AXNX$432M

BMRA$4M

Revenue Growth (YoY)

AXNX26.1%

BMRA-16.2%

Forward Rev Growth

AXNX0.0%

BMRA0.0%

Gross Margin (TTM)

AXNX76.6%

BMRA8.1%

Operating Margin (TTM)

AXNX0.0%

BMRA0.0%

EBITDA Margin (TTM)

AXNX1.2%

BMRA-117.8%

Net Margin (TTM)

AXNX-1.3%

BMRA-84.8%

FCF Margin (TTM)

AXNX1.2%

BMRA-77.7%

Net Income (TTM)

AXNX$-6M

BMRA$-4M

FCF (TTM)

AXNX$5M

BMRA$-3M

EPS (TTM)

AXNX-$0.11

BMRA-$1.22

ROE (TTM)

AXNX-88.0%

BMRA-9719.0%

ROA (TTM)

AXNX-77.0%

BMRA-6157.0%

ROIC (TTM)

AXNX-88.0%

BMRA-9416.0%

Cash

AXNX$239M

BMRA$1M

Debt

AXNX$0

BMRA$500K

Net Cash/Debt

AXNX$239M

BMRA$808K

Current Ratio (TTM)

AXNX8.16x

BMRA1.62x

Quick Ratio (TTM)

AXNX6.33x

BMRA0.84x

Debt/Equity (TTM)

AXNX0.00x

BMRA0.19x

Debt/Assets (TTM)

AXNX0.0%

BMRA0.0%

Interest Coverage (TTM)

AXNXN/A

BMRAN/A

Net Debt/EBITDA (TTM)

AXNX0.00x

BMRA0.00x

Beta

AXNX3.24

BMRA0.39

52W Performance

AXNX-98.8%

BMRA-34.6%

YTD Performance

AXNX-0.1%

BMRA-26.9%

% from 52W High

AXNX-99.0%

BMRA-42.4%

% from 52W Low

AXNX1.4%

BMRA27.6%

Asset Turnover (TTM)

AXNX0.58x

BMRA0.73x

FCF Yield (TTM)

AXNX14.8%

BMRA-60.5%

Earnings Yield (TTM)

AXNX-15.6%

BMRA-66.0%

Dividend Yield (TTM)

AXNXN/A

BMRAN/A

Rule of 40

AXNX27.3

BMRA-93.8

EV/GP/RG

AXNXN/A

BMRAN/A

Ticker research

View AXNX research View BMRA research

Metric	AXNX Axonics Inc	BMRA Biomerica Inc
Market & Valuation
Market Cap	$36M	$6M
Enterprise Value	$-203M	$5M
Price	$0.71	$1.85
P/E Ratio	N/A	N/A
P/S Ratio	0.08x	1.28x
EV/Sales	-0.47x	1.10x
EV/EBITDA	-58.64x	29.35x
P/B Ratio	0.02x	3.21x
P/FCF Ratio	6.75x	N/A
EV/FCF	-37.80x	-1.42x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	1.40x	N/A
Forward P/S (NTM)	0.07x	N/A
Revenue & Growth
Revenue (TTM)	$432M	$4M
Revenue Growth (YoY)	26.1%	-16.2%
Forward Rev Growth	0.0%	0.0%
Profitability
Gross Margin (TTM)	76.6%	8.1%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	1.2%	-117.8%
Net Margin (TTM)	-1.3%	-84.8%
FCF Margin (TTM)	1.2%	-77.7%
Net Income (TTM)	$-6M	$-4M
FCF (TTM)	$5M	$-3M
EPS (TTM)	-$0.11	-$1.22
ROE (TTM)	-88.0%	-9719.0%
ROA (TTM)	-77.0%	-6157.0%
ROIC (TTM)	-88.0%	-9416.0%
Financial Health
Cash	$239M	$1M
Debt	$0	$500K
Net Cash/Debt	$239M	$808K
Current Ratio (TTM)	8.16x	1.62x
Quick Ratio (TTM)	6.33x	0.84x
Debt/Equity (TTM)	0.00x	0.19x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	3.24	0.39
52W Performance	-98.8%	-34.6%
YTD Performance	-0.1%	-26.9%
% from 52W High	-99.0%	-42.4%
% from 52W Low	1.4%	27.6%
Efficiency & Yields
Asset Turnover (TTM)	0.58x	0.73x
FCF Yield (TTM)	14.8%	-60.5%
Earnings Yield (TTM)	-15.6%	-66.0%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	27.3	-93.8
EV/GP/RG	N/A	N/A
Ticker research	View AXNX research	View BMRA research